Mathias Lilja

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Advanced Non Small Cell Lung Cancer

Top Venues

Leukemia & lymphoma

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Christoph Abé, Jaana Keto, Mathias Lilja, Mie Konradsen, Johan Mesterton, Martin Höglund, Vladimir Lj Lazarevic, Sören Lehmann, Gunnar Juliusson
Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data. Leukemia & lymphoma (2024)
Christoph Abé, Jaana Keto, Mathias Lilja, Mie Konradsen, Johan Mesterton, Martin Höglund, Vladimir Lj Lazarevic, Sören Lehmann, Gunnar Juliusson
Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data. Leukemia & lymphoma (2024)
Rosa Lauppe, Fredrik O L Nilsson, Hanna Fues Wahl, Mathias Lilja, Anders Vikström, Sandra T Asanin
Use of ALK-tyrosine kinase inhibitors (ALK TKI) in clinical practice, overall survival, and treatment duration - a Swedish nationwide retrospective study. Acta oncologica (Stockholm, Sweden) 61 (11) (2022)